PlumX Metrics
Embed PlumX Metrics

Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression

Cancer and Metastasis Reviews, ISSN: 0167-7659, Vol: 31, Issue: 1-2, Page: 195-208
2012
  • 428
    Citations
  • 0
    Usage
  • 376
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy

Introduction Nowadays, cancer remains one of the leading causes of death globally, accounting for more than 10 million deaths each year. CAFs has garnered increasing

Review Description

Several recent papers have now provided compelling experimental evidence that the progression of tumours towards a malignant phenotype does not depend exclusively on the cell-autonomous properties of cancer cells themselves but is also deeply influenced by tumour stroma reactivity, thereby undergoing a strict environmental control. Tumour microenvironmental elements include structural components such as the extracellular matrix or hypoxia as well as stromal cells, either resident cells or recruited from circulating precursors, as macrophages and other inflammatory cells, endothelial cells and cancer-associated fibroblasts (CAFs). All these elements synergistically play a specific role in cancer progression. This review summarizes our current knowledge on the role of CAFs in tumour progression, with a particular focus on the biunivocal interplay between CAFs and cancer cells leading to the activation of the epithelial-mesenchymal transition programme and the achievement of stem cell traits, as well as to the metabolic reprogramming of both stromal and cancer cells. Recent advances on the role of CAFs in the preparation of metastatic niche, as well as the controversial origin of CAFs, are discussed in light of the new emerging therapeutic implications of targeting CAFs. © 2011 Springer Science+Business Media, LLC.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know